Luna Innovations has entered a joint marketing alliance agreement with the Japanese-based Terumo Cardiovascular Systems (CVS), supplier of cardiopulmonary bypass products.

Under the terms of this agreement, Luna and Terumo CVS will market Luna’s emboli detection and classification (EDAC) Quantifier for clinical use in the United States.

The FDA-approved EDAC Quantifier is a standalone emboli detection system that uses quantitative ultrasound technology to non-invasively detect gaseous emboli in up to three extracorporeal bypass circuit lines, according to the Roanoke, Va.-based Luna.